Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 16 Apr 2021

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC

in Thoracic Oncology

Ya Chen
Zhengyu Yang
Yanan Wang
Minjuan Hu
Bo Zhang
Yanwei Zhang
Fangfei Qian
Wei Zhang
Baohui Han

Frontiers in Oncology

doi 10.3389/fonc.2021.671228

6,008 views
28 citations

Original Research

Published on 16 Apr 2021

Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates

in Thoracic Oncology

Jing Su
Lynn S. Huang
Ryan Barnard
Graham Parks
James Cappellari
Christina Bellinger
Travis Dotson
Lou Craddock
Bharat Prakash
Jonathan Hovda

Frontiers in Oncology

doi 10.3389/fonc.2021.584896

2,976 views
5 citations

Review

Published on 15 Apr 2021

Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities

in Thoracic Oncology

Miriam Grazia Ferrara
Alessio Stefani
Michele Simbolo
Sara Pilotto
Maurizio Martini
Filippo Lococo
Emanuele Vita
Marco Chiappetta
Alessandra Cancellieri
Ettore D’Argento

Frontiers in Oncology

doi 10.3389/fonc.2021.650293

21,299 views
45 citations

Original Research

Published on 15 Apr 2021

The Expression of Three Negative Co-Stimulatory B7 Family Molecules in Small Cell Lung Cancer and Their Effect on Prognosis

in Thoracic Oncology

Meng-jun Qiu
Qin Xia
Yao-bing Chen
Xie-fan Fang
Qiu-ting Li
Li-sheng Zhu
Xin Jiang
Zhi-fan Xiong
Sheng-li Yang

Frontiers in Oncology

doi 10.3389/fonc.2021.600238

6,532 views
18 citations

Original Research

Published on 15 Apr 2021

Combination of Bempegaldesleukin and Anti-CTLA-4 Prevents Metastatic Dissemination After Primary Resection or Radiotherapy in a Preclinical Model of Non-Small Cell Lung Cancer

in Thoracic Oncology

Amber M. Bates
Ryan J. Brown
Alexander A. Pieper
Luke M. Zangl
Ian Arthur
Peter M. Carlson
Trang Le
Gustavo A. Sosa
Paul A. Clark
Raghava N. Sriramaneni

Frontiers in Oncology

doi 10.3389/fonc.2021.645352

4,592 views
3 citations

Review

Published on 15 Apr 2021

Transition of Treatment for Ground Glass Opacity–Dominant Non-Small Cell Lung Cancer

in Thoracic Oncology

Yoshinori Handa
Yasuhiro Tsutani
Morihito Okada

Frontiers in Oncology

doi 10.3389/fonc.2021.655651

7,912 views
20 citations

Systematic Review

Published on 13 Apr 2021

First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

in Thoracic Oncology

Qiang Wu
Wuxia Luo
Wen Li
Ting Wang
Lin Huang
Feng Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.598265

8,654 views
37 citations

Original Research

Published on 12 Apr 2021

Prognostic Impact of Radiological Consolidation Tumor Ratio in Clinical Stage IA Pulmonary Ground Glass Opacities

in Thoracic Oncology

Junjie Xi
Jiacheng Yin
Jiaqi Liang
Cheng Zhan
Wei Jiang
Zongwu Lin
Songtao Xu
Qun Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.616149

6,012 views
38 citations

Original Research

Published on 12 Apr 2021

Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Shetal A. Patel
David E. Gerber
Allison Deal
Kathe Douglas
Chad V. Pecot
Carrie Lee
Joan Schiller
Nirav Dhruva
Jared Weiss

Frontiers in Oncology

doi 10.3389/fonc.2021.666691

8,627 views
2 citations

Systematic Review

Published on 12 Apr 2021

Adjuvant EGFR-TKIs for Patients With Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis of 1,283 Patients

in Thoracic Oncology

Rui-Lian Chen
Ling-Ling Sun
Yang Cao
Han-Rui Chen
Jing-Xu Zhou
Chu-Ying Gu
Ying Zhang
Si-Yu Wang
Wei Hou
Li-Zhu Lin

Frontiers in Oncology

doi 10.3389/fonc.2021.629394

6,557 views
27 citations

Original Research

Published on 09 Apr 2021

De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer

in Thoracic Oncology

Farastuk Bozorgmehr
Daniel Kazdal
Inn Chung
Martina Kirchner
Nikolaus Magios
Mark Kriegsmann
Michael Allgäuer
Laura V. Klotz
Thomas Muley
Rami A. El Shafie

Frontiers in Oncology

doi 10.3389/fonc.2021.640048

4,519 views
5 citations

Case Report

Published on 07 Apr 2021

Lung Adenocarcinoma Patient Harboring EGFR-KDD Achieve Durable Response to Afatinib: A Case Report and Literature Review

in Thoracic Oncology

Lingling Zhao
Zhen Wang
Haiwei Du
Songan Chen
Pingli Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.605853

2,985 views
7 citations

Original Research

Published on 07 Apr 2021

Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients

in Thoracic Oncology

Jie Yang
Hefei Li
Ben Li
Wei Li
Qiang Guo
Ling Hu
Zizheng Song
Bin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.647598

6,534 views
11 citations

Original Research

Published on 31 Mar 2021

Algorithm-Based Meta-Analysis Reveals the Mechanistic Interaction of the Tumor Suppressor LIMD1 With Non-Small-Cell Lung Carcinoma

in Thoracic Oncology

Ling Wang
Ayrianna Sparks-Wallace
Jared L. Casteel
Mary E. A. Howell
Shunbin Ning

Frontiers in Oncology

doi 10.3389/fonc.2021.632638

4,374 views
6 citations

Original Research

Published on 31 Mar 2021

New Perspectives in Different Gene Expression Profiles for Early and Locally Advanced Non-Small Cell Lung Cancer Stem Cells

in Thoracic Oncology

Valentina Masciale
Federico Banchelli
Giulia Grisendi
Roberto D’Amico
Antonino Maiorana
Alessandro Stefani
Uliano Morandi
Massimo Dominici
Beatrice Aramini

Frontiers in Oncology

doi 10.3389/fonc.2021.613198

3,565 views
13 citations

Original Research

Published on 30 Mar 2021

The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy

in Thoracic Oncology

Alex Friedlaender
Petros Tsantoulis
Mathieu Chevallier
Claudio De Vito
Alfredo Addeo

Frontiers in Oncology

doi 10.3389/fonc.2021.644472

10,565 views
25 citations